One experimental injection helped mice and pigs heal after heart attack by boosting a protective heart hormone. (CREDIT: ...
Morning Overview on MSN
Single intramuscular shot shows promise for faster heart attack recovery
A single intramuscular injection of a self-amplifying RNA therapy produced weeks of heart-protective protein in rat models of myocardial infarction, according to a study published in Science on March ...
Paulick Report on MSN
New Betamethasone Study Quantifies Detection Time For Intramuscular Use
A study published in the Journal of Veterinary Pharmacology and Therapeutics on Feb. 7, 2026, has quantified the amount of ...
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly ...
A single injection may help the heart heal for weeks after a heart attack by prompting the body to release a natural protective hormone.
Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
Kesimpta is a biologic drug, which means it’s made from parts of living organisms. It contains the active ingredient ofatumumab. Kesimpta belongs to a group of drugs called monoclonal antibodies. It ...
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Testosterone cream is a needle-free testosterone therapy that can effectively raise hormone levels. Benefits include improved ...
Researchers developed an RNA-based injection that prompts muscle cells to produce a natural heart-protective hormone for ...
Prospective cohort finds botulinum neurotoxin injection improved sleep quality in cervical dystonia, with no significant mood ...
BY MAIRE O’NEILLmaire@losalamosreporter.com Officials from the New Mexico Environment Department will attend the Board of ...
Tuko News on MSN
Kawangare delivery man becomes first person to use long-acting HIV prevention injection, Lenacapavir
Samson Mutua, 27, is the first Kenyan to receive Lenacapavir, a long-acting HIV prevention injection, marking a significant ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果